Matches in SemOpenAlex for { <https://semopenalex.org/work/W2883454293> ?p ?o ?g. }
- W2883454293 endingPage "105" @default.
- W2883454293 startingPage "96" @default.
- W2883454293 abstract "Biofilms present a major problem to industry and healthcare worldwide. Composed of a population of surface-attached microbial cells surrounded by a protective extracellular polysaccharide matrix, they are responsible for increased tolerance to antibiotics, treatment failure and a resulting rise in antimicrobial resistance. Here we demonstrate that self-assembled peptide nanostructures composed of a diphenylalanine motif provide sufficient antibacterial activity to eradicate mature biofilm forms of bacteria widely implicated in hospital infections. Modification of terminal functional groups to amino (–NH2), carboxylic acid (–COOH) or both modalities, and switch to d-isomers, resulted in changes in antibacterial selectivity and mammalian cell toxicity profiles. Of the three peptide nanotubes structures studied (NH2-FF-COOH, NH2-ff-COOH and NH2-FF-NH2), NH2-FF-COOH demonstrated the most potent activity against both planktonic (liquid, free-floating) and biofilm forms of bacteria, possessing minimal mammalian cell toxicity. NH2-FF-COOH resulted in greater than 3 Log10 CFU/mL viable biofilm reduction (>99.9%) at 5 mg/mL and total biofilm kill at 10 mg/mL against Staphylococcus aureus after 24 h exposure. Scanning electron microscopy proved that antibiofilm activity was primarily due to the formation of ion channels and/or surfactant-like action, with NH2-FF-COOH and NH2-ff-COOH capable of degrading the biofilm matrix and disrupting cell membranes, leading to cell death in Gram-positive bacterial isolates. Peptide-based nanotubes are an exciting platform for drug delivery and engineering applications. This is the first report of using peptide nanotubes to eradicate bacterial biofilms and provides evidence of a new platform that may alleviate their negative impact throughout society. We outline, for the first time, the antibiofilm activity of diphenylalanine (FF) peptide nanotubes. Biofilm bacteria exhibit high tolerance to antimicrobials 10–10,000 times that of free-flowing planktonic forms. Biofilm infections are difficult to treat using conventional antimicrobial agents, leading to a rise in antimicrobial resistance. We discovered nanotubes composed of NH2-FF-COOH demonstrated potent activity against staphylococcal biofilms implicated in hospital infections, resulting in complete kill at concentrations of 10 mg/mL. Carboxylic acid terminated FF nanotubes were able to destroy the exopolysaccharide architecture of staphylococcal biofilms expressing minimal toxicity, highlighting their potential for use in patients. Amidated (NH2-FF-NH2) forms demonstrated reduced antibiofilm efficacy and significant toxicity. These results contribute significantly to the development of innovative antibacterial technologies and peptide nanomaterials." @default.
- W2883454293 created "2018-08-03" @default.
- W2883454293 creator A5001973427 @default.
- W2883454293 creator A5005541110 @default.
- W2883454293 creator A5053479755 @default.
- W2883454293 creator A5066921126 @default.
- W2883454293 creator A5077659528 @default.
- W2883454293 date "2018-09-01" @default.
- W2883454293 modified "2023-10-14" @default.
- W2883454293 title "Self-assembling diphenylalanine peptide nanotubes selectively eradicate bacterial biofilm infection" @default.
- W2883454293 cites W1560177375 @default.
- W2883454293 cites W1878404532 @default.
- W2883454293 cites W1885513900 @default.
- W2883454293 cites W1963808808 @default.
- W2883454293 cites W1969160571 @default.
- W2883454293 cites W1971472529 @default.
- W2883454293 cites W1982228392 @default.
- W2883454293 cites W1990450973 @default.
- W2883454293 cites W1992774222 @default.
- W2883454293 cites W1994726986 @default.
- W2883454293 cites W2009106357 @default.
- W2883454293 cites W2011347701 @default.
- W2883454293 cites W2011904099 @default.
- W2883454293 cites W2012126086 @default.
- W2883454293 cites W2012304333 @default.
- W2883454293 cites W2013738716 @default.
- W2883454293 cites W2017268899 @default.
- W2883454293 cites W2032632254 @default.
- W2883454293 cites W2039308356 @default.
- W2883454293 cites W2049135139 @default.
- W2883454293 cites W2054602599 @default.
- W2883454293 cites W2059223510 @default.
- W2883454293 cites W2061685908 @default.
- W2883454293 cites W2079665383 @default.
- W2883454293 cites W2080807247 @default.
- W2883454293 cites W2106351298 @default.
- W2883454293 cites W2107290421 @default.
- W2883454293 cites W2108629610 @default.
- W2883454293 cites W2117630026 @default.
- W2883454293 cites W2147652807 @default.
- W2883454293 cites W2152539295 @default.
- W2883454293 cites W2155552706 @default.
- W2883454293 cites W2164432723 @default.
- W2883454293 cites W2168879981 @default.
- W2883454293 cites W2189940801 @default.
- W2883454293 cites W2212629349 @default.
- W2883454293 cites W2223219991 @default.
- W2883454293 cites W2294858745 @default.
- W2883454293 cites W2320163753 @default.
- W2883454293 cites W2322972210 @default.
- W2883454293 cites W2462484294 @default.
- W2883454293 cites W2469473340 @default.
- W2883454293 cites W2523649862 @default.
- W2883454293 cites W2536928971 @default.
- W2883454293 cites W2560533661 @default.
- W2883454293 cites W2592316917 @default.
- W2883454293 cites W2623261556 @default.
- W2883454293 cites W2766262938 @default.
- W2883454293 cites W2774385845 @default.
- W2883454293 doi "https://doi.org/10.1016/j.actbio.2018.07.033" @default.
- W2883454293 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30031161" @default.
- W2883454293 hasPublicationYear "2018" @default.
- W2883454293 type Work @default.
- W2883454293 sameAs 2883454293 @default.
- W2883454293 citedByCount "61" @default.
- W2883454293 countsByYear W28834542932019 @default.
- W2883454293 countsByYear W28834542932020 @default.
- W2883454293 countsByYear W28834542932021 @default.
- W2883454293 countsByYear W28834542932022 @default.
- W2883454293 countsByYear W28834542932023 @default.
- W2883454293 crossrefType "journal-article" @default.
- W2883454293 hasAuthorship W2883454293A5001973427 @default.
- W2883454293 hasAuthorship W2883454293A5005541110 @default.
- W2883454293 hasAuthorship W2883454293A5053479755 @default.
- W2883454293 hasAuthorship W2883454293A5066921126 @default.
- W2883454293 hasAuthorship W2883454293A5077659528 @default.
- W2883454293 hasBestOaLocation W28834542932 @default.
- W2883454293 hasConcept C185592680 @default.
- W2883454293 hasConcept C192562407 @default.
- W2883454293 hasConcept C19655278 @default.
- W2883454293 hasConcept C21951064 @default.
- W2883454293 hasConcept C2779281246 @default.
- W2883454293 hasConcept C2779489039 @default.
- W2883454293 hasConcept C2780104969 @default.
- W2883454293 hasConcept C4937899 @default.
- W2883454293 hasConcept C501593827 @default.
- W2883454293 hasConcept C523546767 @default.
- W2883454293 hasConcept C540938839 @default.
- W2883454293 hasConcept C54355233 @default.
- W2883454293 hasConcept C55493867 @default.
- W2883454293 hasConcept C58123911 @default.
- W2883454293 hasConcept C86803240 @default.
- W2883454293 hasConcept C89423630 @default.
- W2883454293 hasConceptScore W2883454293C185592680 @default.
- W2883454293 hasConceptScore W2883454293C192562407 @default.
- W2883454293 hasConceptScore W2883454293C19655278 @default.
- W2883454293 hasConceptScore W2883454293C21951064 @default.
- W2883454293 hasConceptScore W2883454293C2779281246 @default.